TG Therapeutics Inc. Stock
TG Therapeutics Inc. Stock
TG Therapeutics Inc. gained 2.090% today.
We see a rather positive sentiment for TG Therapeutics Inc. with 11 Buy predictions and 1 Sell predictions.
With a target price of 55 € there is a positive potential of 27.61% for TG Therapeutics Inc. compared to the current price of 43.1 €.
So far the community has only identified positive things for TG Therapeutics Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of TG Therapeutics Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
S********** s********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of TG Therapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| TG Therapeutics Inc. | 2.090% | -4.435% | -15.157% | 80.146% | 65.801% | 370.216% | 115.177% |
| Evolus Inc | 2.620% | 5.140% | -10.131% | 4.419% | 0.587% | -38.404% | -43.485% |
| Heron Therapeutics Inc. | -2.600% | -2.739% | 12.453% | -73.548% | -62.388% | -72.792% | -95.833% |
| Rhythm Pharmaceuticals | -1.050% | 3.279% | -1.563% | 24.342% | 1.070% | 333.486% | 707.692% |
Comments
TG Therapeutics (TGTX) had its price target raised by JPMorgan Chase & Co. from $65.00 to $72.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for TGTX provided by MarketBeat
TG Therapeutics (TGTX) had its "buy" rating reaffirmed by B. Riley Financial, Inc..
Show more
Ratings data for TGTX provided by MarketBeat
TG Therapeutics (TGTX) had its price target raised by HC Wainwright from $70.00 to $77.00. They now have a "buy" rating on the stock.
Show more
Ratings data for TGTX provided by MarketBeat